(Q40540422)

21 September 2017

title

Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy (English)

1 reference

21 September 2017

1 reference

Gary H Lyman

1

1 reference

21 September 2017

Vicki A Morrison

2

1 reference

21 September 2017

David C Dale

3

1 reference

21 September 2017

Jeffrey Crawford

4

1 reference

21 September 2017

David J Delgado

5

1 reference

21 September 2017

Moshe Fridman

6

1 reference

21 September 2017

OPPS Working Group

7

1 reference

21 September 2017

ANC Study Group

8

1 reference

21 September 2017

publication date

1 December 2003

1 reference

21 September 2017

1 reference

21 September 2017

volume

44

1 reference

21 September 2017

issue

12

1 reference

21 September 2017

page(s)

2069-2076

1 reference

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000119262

The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate-grade non-Hodgkin's lymphoma receiving initial CHOP chemotherapy: a risk factor analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000119262

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000119262

Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000119262

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000119262

Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000119262

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000119262

First-cycle blood counts and subsequent neutropenia, dose reduction, or delay in early-stage breast cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000119262

Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000119262

10.1080/1042819031000119262

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference